Donate Connect
SEARCH

FOP News

University of Michigan Publishes Article Identifying Different Immune Cell Types Post Injury

Posted by · February 14, 2020 10:19 AM
Read more Share

Important Announcement and Letter from Ipsen Regarding the MOVE Trial and a Pause in Dosing

Posted by · January 24, 2020 9:47 AM
Read more Share

Regeneron Releases Phase 2 Trial Results and Shares Next Steps

Posted by · January 15, 2020 10:57 AM
Read more Share

Regeneron Pharmaceutical Releases Results of Phase 2 of the LUMINA-1 Trial

Posted by · January 09, 2020 9:09 AM
Read more Share

An Important Update from Ipsen Regarding the Palovarotene Trial for Children Under 14

Posted by · December 13, 2019 10:01 AM
Read more Share

Important Announcement about the MOVE Trial for Children Under 14

Posted by · December 06, 2019 7:00 AM
Read more Share

Exciting News from BioCryst Pharmaceuticals

Posted by · November 01, 2019 10:53 AM

BioCryst launches Phase 1 trial for FOP

Read more Share

An Important Announcement from Blueprint Medicines & Ipsen

Posted by · October 16, 2019 11:01 AM

Ipsen and Blueprint enter exclusive agreement in FOP

Read more Share

ASBMR 2019 Presentations

Posted by · September 20, 2019 2:53 PM

11 FOP Presentations Will Be Made At The Annual Meeting

Read more Share

Dr. Maurizio Pacifici’s Research Inspired Two Clinical Trials

Posted by · August 28, 2019 2:49 PM

Learn how research on RAR gamma agonists motivated the Palovarotene clinical trials  

Read more Share

Learn More

Is it FOP? Just Diagnosed Registry

Make a Difference

Donate Connect Fundraise
Sign in with Facebook, Twitter or email.
Site by Mosaic • Created with NationBuilder
Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter